Tower Research Capital »

Aspire Biopharma Hldgs shares owned by Tower Research Capital

Quarter-by-quarter ownership of Aspire Biopharma Hldgs (ASBP) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Aspire Biopharma Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Aspire Biopharma Hldgs held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aspire Biopharma Hldgs by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.4k 31k 0.21

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for Tower Research Capital

Top funds holding Aspire Biopharma Hldgs

Crewe Advisors
Procyon Private Wealth Partners
Vanguard Group
Optivise Advisory Services
Geode Capital Management
Antara Capital
VR Advisory Services
Resolute Advisors
Three Seasons Wealth
P. Schoenfeld Asset Management
Efficient Wealth Management
Periscope Capital
Atlantic Trust
Hallmark Capital Management
Platform Technology Partners

View all funds holding Aspire Biopharma Hldgs